Diversity in Patients With OAB

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Overactive BladderDiversityOnabotulinum Toxin ASacral NeuromodulationDiscrete Choice Experiment
Interventions
OTHER

Questionnaires

Patients fill in a questionnaire

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
collaborator

AZ Sint-Lucas Gent

OTHER

collaborator

AZ Jan Palfijn Gent

OTHER

collaborator

Algemeen Ziekenhuis Maria Middelares

OTHER

lead

University Hospital, Ghent

OTHER

NCT05903105 - Diversity in Patients With OAB | Biotech Hunter | Biotech Hunter